The STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) were published in fi ve journals in 2001 and 2002. These guidelines, in the form of a checklist and explanations for use by authors and journal editors, were designed to improve reporting of acupuncture trials, particularly the interventions, thereby facilitating their interpretation and replication. Subsequent reviews of the application and impact of STRICTA have highlighted the value of STRICTA as well as scope for improvements and revision.
INTRODUCTION
The STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) reporting guidelines, fi rst published in 2001, [1] [2] [3] [4] [5] [6] [7] [8] [9] were designed to improve the completeness and transparency of reporting of interventions in controlled trials of acupuncture, in order that such trials may be more accurately interpreted and readily replicated. STRICTA comprised a checklist that expanded the generic content of item 4 of the CONSORT statement, 10 11 which relates to the reporting of the intervention.
A survey of authors of clinical trials and systematic reviews was subsequently conducted to determine the usefulness The combination of these developments led to an agreement between the CONSORT Group and the STRICTA Group, in collaboration with the Chinese Cochrane Centre and the Chinese Centre for Evidence-based Medicine, to revise STRICTA as a formal extension to CONSORT. The revision processes have been described in more detail elsewhere. 17 This paper describes the outcome and new checklist, updated explanations and published examples of good reporting.
METHODS
In the summer of 2008, a group of 47 experts from the original STRICTA Group, the CONSORT Group, the World Federation of Acupuncture and Moxibustion Societies, the Acupuncture Trialists' Collaboration, 18 the Society for Acupuncture Research 19 and clinical trial authors were surveyed. 12 The experts were from 15 countries, 41 had academic positions, 31 were acupuncturists, 18 were involved with journals, such as board members, 15 were doctors and 11 had previously helped in developing reporting guidelines. These experts were consulted about a draft of revised STRICTA items that had evolved from previous research. 12 13 Feedback was collated and forwarded (with permission) to those invited to a consensus development workshop, the next phase of the revision process.
Twenty-one people attended a workshop in Freiburg, Germany, in October 2008. The attendees included experts in epidemiology, trial methodology, statistics and medical journal editing. Just over half the participants were acupuncturists from a variety of backgrounds, including doctors and non-doctors. All attendees received collated feedback from the 47 experts, together with a draft revised STRICTA checklist for consideration.
The workshop comprised presentations about the history of STRICTA, CONSORT and the then new CONSORT non-pharmacological treatments extension. 14 15 The results of two investigations into the utility and acceptability of STRICTA, 12 13 and the subsequent consultation with the 47 experts, were also presented. A general discussion and agreement on generic issues relating to STRICTA were followed by a discussion of each nominated checklist item. The aim was to agree, where possible, on the content of the updated draft checklist as well as to develop a revised set of explanations for each included item.
Subsequent to the workshop, a small writing group edited drafts of the revised STRICTA checklist, identifying for each item one or more exemplars of good reporting, and developed text explaining the rationale and discussing relevant evidence. Taking into account further feedback from those attending the Freiburg workshop, the writing group fi nalised the STRICTA checklist, the explanations and the examples of good reporting.
RESULTS
There was agreement that STRICTA should continue to function as a standalone guideline for reporting acupuncture studies and be an offi cial extension of CONSORT for reporting randomised controlled trials. There was also consensus on a minor change of name, in that the word 'controlled' in STRICTA should be replaced by 'clinical', to indicate that it was applicable for reporting a broad range of clinical evaluation designs, including uncontrolled outcome studies and case reports. The group agreed that the rationale behind reporting should be to provide the information needed to allow replication of a study, reduce ambiguity and enhance transparency. The group recognised that acupuncture trials inevitably differ in the degree of individualisation of care that is permitted and agreed that the reporting guideline should acknowledge this and be applicable across the whole range of designs. The group also suggested that the revised STRICTA statement, when published, should be presented as embedded within the two-group parallel trial CONSORT checklist 10 and its nonpharmacological treatment extension checklist. 14 The revised STRICTA checklist comprises six items split into 17 subitems (table  1) . Table 2 presents details of the way in which the revised STRICTA checklist fi ts within the CONSORT checklist 10 and its extension for non-pharmacological treatments.
14 Below we provide the checklist text for each of the six items and their subitems, as well as explanations on the need for their adequate reporting and examples of good reporting from the published literature. The author(s) should provide the reasoning for the chosen treatment, including rationale for diagnosis, point selection and treatment procedures. The 'rules' that were used in providing treatments should be described. When treatments were selected that have roots in traditional practice, it is recommended that the historical and cultural context be supplied. This is relevant for interventions within styles such as Traditional Chinese Medicine, where the broad diversity of approaches . The fi rst step involved three specialists (names provided) and the study team developing a proposal, which was followed by a discussion including more than 30 acupuncture experts from both acupuncture societies. The fi nal intervention strategies were defi ned by the above-mentioned three specialists together with the study team and subsequently were communicated to the external advisors.
STRICTA
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Item 1c: Extent to which treatment was varied Explanation
The extent to which the treatment was individualised, both between patients and between practitioners, should be described. Trial protocols choose one of the three broad levels of individualisation, ranging from none at all (all patients receiving the same treatment at all sessions), through partially individualised treatments (eg, use of a fi xed set of points to be combined with a set of points to be used fl exibly), to fully individualised treatment protocols within which each patient receives a unique and evolving diagnosis and treatment. Additionally, the practitioners may have to apply a standardised theoretical framework or may be allowed to apply their own. Many styles of acupuncture, whether based on traditional theories or Westernised concepts such as trigger points, are individualised in routine practice. Trials that are more pragmatic 28 in their aim, and designed to replicate routine settings and patient groups, place more of an emphasis on fully individualised treatment. In such cases standardisation may consist of a protocol that instructs practitioners to provide treatments as they normally do. Trials that are more explanatory (mechanistic) in their aim tend to need a tighter defi nition of specifi c components in order to minimise variation across treatments. It is recommended that the reporting of this item should include a total of needle insertions per subject per session. This item is relevant to all designs of randomised controlled trials, from pragmatic to explanatory. For more explanatory designs where a formula of points is prescribed, the number of needle insertions should be reported as a simple total. For more pragmatic designs, with individualised treatments, the mean and range should be reported. Clearly, full details of individualised treatment cannot be reported in every section of item 2 below. However, each item should be considered and as much information given as possible.
Examples
(A) The protocol allowed for up to 10 treatments per patient, the precise number being agreed between patient and practitioner. A total of 1269 treatments were provided, an average of 8.6 treatments per patient (range 1-10) and 9.6 needles per treatment (range 6-12). See ( The specifi c point locations used in treatments where standardised should be described by an accepted nomenclature (eg, GB21) 35 or by an anatomical location where there is no accepted name. Whether the needles are inserted unilaterally or bilaterally should be stated. For protocols with partially individualised prescriptions, list any prescribed essential or optional points, and describe (in the Results section) both the points used at every visit, and all the points used on an ad hoc basis. If the list is extensive, the most commonly used points (with percentages) should be reported. Where protocols specify using fully individualised point prescriptions, authors should consider the best way to report the points used-for example, by listing all points across all subjects or by identifying the most commonly used points if the list is extensive. 
Item 2c: Depth of insertion, based on a specifi ed unit of measurement or on a particular tissue level Explanation
The depth of insertion should be expressed using the Chinese measurement of the cun; as anatomical depth-for example, of subcutaneous tissue, fascia, muscle or periosteum; or in millimetres. For some trials, the protocol might specify the angle and direction of insertion together with depth of insertion, in which case these should also be reported.
Examples
(A) All needle placements were performed by an experienced acupuncturist at a premarked depth of 4 mm from the tip of the needle. 37 (B) The depth of needle insertion varied with thickness of the skin and subcutaneous fatty tissues at the site of the acupuncture points; it was usually 1-1.5 cm. 38 (C) Shallow and light needling stimulation (1-2 mm) using fi ne needles (0.18-0.16 mm) inserted with the aid of insertion tubes was emphasised.
Points were needled at a 10-20° angle with a two-hand needling technique, generally in the direction of the fl ow of the channel.
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Item 2d: Response sought (eg, de qi or muscle twitch response) Explanation
If the study protocol requires that specifi c responses to needling be elicited-for example, the de qi sensation in traditional Chinese acupuncture, the muscle twitch in trigger point treatment or muscle contraction in electroacupuncture, these elicited responses should be reported. Where relevant, the authors should differentiate between the responses required in the protocol and those actually obtained (which should be reported in the Results section).
Examples
(A) The trigger point group received treatment at trigger points. The correct application of the technique requires experience in palpation and localisation of taut muscle bands and myofascial trigger points. Precise needling of myofascial trigger points provokes a brief contraction of the muscle fi bres. This local twitch response must be elicited for successful therapy but it may be painful and post-treatment soreness is frequent. 33 (B) In contrast with TCM-style acupuncture, we did not employ vigorous manipulation in order to elicit a strong de qi sensation (defi ned as a feeling of heaviness around the acupuncture point). (ref) Practitioners focused instead on feeling the response to stimulation as an 'echo' sensation experienced on the receiving hand, while the active hand performed the actual needling. Attention was placed on reactivity or change in diagnostic areas, especially the pulse and abdomen. By carefully assessing changes in palpatory fi ndings, the treatment was adjusted continuously based on the patient's response. Before needling, the 'live' points were identifi ed by palpation-th at is, subtle changes at the skin level, or upon touch or pressure, for that particular patient.
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Item 2e: Needle stimulation (eg, manual, electrical) Explanation
Needle stimulation techniques, where used, should be clearly described for all points. For manual stimulation, such techniques include lifting, thrusting or rotating the needle to manipulate the de qi sensation. For electrical stimulation, the current, amplitude and frequency settings should be recorded.
Examples
(A) This mode of (manual) stimulation was provided via the acupuncture needles, which were placed in the premarked depth at the marked sites. The needle was rotated by an experienced acupuncturist with the index fi nger and thumb in an alternating clockwise and counter-clockwise fashion at the rate of three to fi ve rotations per second. 37 (B) Electrical stimulation was given to the anterior part of the knee for 10 min and then 10 min for the posterior part using a battery-operated, four-channel, 'AS Super 4' Electrostimulator (RDG Medical, Surrey, UK) which generated low-frequency, square-wave (2-10 Hz) pulses of 1 ms duration for 10 min. (ref) In both groups, the apparatus was attached to needles at the two Xiyan points, SP9 and GB34, and BL40 and BL57. Electrical stimulation was delivered at 6 Hz at a constant current. Voltage was set at a level just above the pain threshold.
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Item 2f: Needle retention time Explanation
Needle retention times should be reported as either a standard or a mean and range. Authors should make it clear that they are reporting the time elapsed between the insertion and removal of needles (retention time) and distinguish it from treatment time, which may include other procedures such as history taking, discussion and preparation for treatment. Additional components of treatment refer to the auxiliary techniques, prescribed self-treatment and lifestyle advice provided by the practitioner. All additional components, whether carried out by the practitioner or patient and whether integral or adjunctive to the acupuncture needling, should be described clearly. For acupuncture-related interventions, such as moxibustion or cupping, detail should be provided equivalent to that recommended for acupuncture needling. If the protocol specifi es the options of prescribed selfhelp treatments such as Qigong or muscle stretching exercises and/or lifestyle advice such as dietary changes based on acupuncture-related diagnostic criteria, then these too must be reported. The frequency with which the advice was given, and participants' compliance with this advice, should be reported. 'Other components of treatment' should be distinguished from 'co-interventions'-that is, interventions that are provided additionally to both groups, which should be fully reported as described in STRICTA item (6b) below.
Examples
Examples (A) In addition to needling, moxibustion or thermal stimulation of the acupoints was used forming very fi ne wool of mugwort (Artemisa vulgaris) into minute, thread-size punks (Okyū) and placing them on a thin layer of a herbal cream (Shiunko). The moxa was lit with an incense stick and the process was repeated several times until warmth was felt by the patient. 39 (B) Following application of the studs, patients were instructed to apply pressure to the stud by making small circular movements with the fi ngers of the opposite hand, 2-3 cycles/s for 1-2 min/point. As is typical for self-administered acupressure, patients were encouraged to apply acupressure this way on waking, in the early afternoon and during any exacerbation of symptoms. Initial instruction was provided verbally, at which time patients were asked to confi rm their understanding by demonstrating the procedure.
Patients also were given easy-to-read written materials describing the acupressure procedure. 45 (C) Chinese herbal medicine was to be taken three times per day over a period of 6 weeks and parallel to acupuncture treatment … All herbs used in the present study were imported from China by a single TCM herbal medicine import company (Sinores, Lueneburg, Germany) … All herbs were prepared in dried, minced pieces and then sealed in generic paper sachets by a pharmacist in order to render the herbal formulation non-identifi able for patients … In addition to the basic formula, every patient received a second additional formula tailored to his or her individual TCM diagnosis.
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Item 4b: Setting and context of treatment, including instructions to practitioners, and information and explanations to patients Explanation
The setting and context of treatment can also provide important additional components to treatment. 47 Context includes instructions to practitioners that might modify their normal practice-for example, prescribing or proscribing explanations to patients about their diagnosis. For patients, the context includes the information they have been given about the trial that might be expected to modify outcomes. Therefore, the information that the patient receives regarding the treatment and control intervention should be reported, including any relevant wording on consent forms and information leafl ets designed to infl uence beliefs or expectations. For example, describing a sham acupuncture control as 'a type of acupuncture' may have a different effect on outcome than saying it is 'not acupuncture, but will involve a similar experience to acupuncture'.
Examples
(A) The fi rst acupuncturist was the 'diagnosing acupuncturist' (DA), whom the patient saw for the initial consultation, and before and after each treatment. A full case history was taken by the DA, together with tongue and pulse examination, to arrive at an individual diagnosis in accordance with the principles of TCM, with an additional lesser emphasis on Five Element Acupuncture (refs) . Although all patients in the study had irritable bowel syndrome, this corresponded to a wide range of TCM patterns, making individual diagnosis essential. Dietary and lifestyle advice (important in treatment according to TCM principles) was given to all patients by the DA, who then selected acupuncture points. The second 'treating acupuncturist' (TA) opened the randomisation envelope, and for the duration of the study remained the only individual aware of treatment allocation. The TA carried out the treatment-either according to instructions issued by the DA or using sham points, depending on the randomisation. 48 (B) Patients were informed about acupuncture and minimal acupuncture in the study as follows: 'in this study, different types of acupuncture will be compared. One type is similar to the acupuncture treatment used in China. The other type does not follow these principles, but has also been associated with positive outcomes in clinical studies'. Characteristics of the acupuncturists providing treatment should be reported, including qualifi cation or affi liation, years in acupuncture practice, as well as any other experience that may be relevant to the trial. Relevant differences (if any) in the qualifi cation, training and experience of the participating acupuncturists should be highlighted. The recent survey of authors of acupuncture trials and reviews reinforced the need for these characteristics to be reported well, 12 especially since the actual level of reporting has historically been poor. 13 In trials where different acupuncturists provide treatment to different treatment arms, the background of both groups should be reported. The eligibility criteria for acupuncturists should be explained, as these will infl uence generalisability of the trial results. Where there are known to be potential variations between practitioners, selecting a random sample of practitioners will reduce expertise bias and help improve the applicability of the results. The physicians had used acupuncture in their practices for an average of 11 years (median 10, range 0-25) and had treated 346 patients (range 22-1200) with acupuncture in the year before the trial. Forty-one physicians (92%) indicated that they frequently or always make a Chinese syndrome diagnosis before starting treatment.
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(B) Eight US-trained and licensed acupuncturists with a median of 10 years of experience (range 4-18 years) provided study treatments in their private offi ces. One investigator trained the acupuncturists in the study procedures to increase their comfort with delivering all four treatments and monitored compliance with the protocol throughout the study. 43 (C) Of the 11 midwives participating in the study, six had been taught acupuncture for mid-wives at the Norwegian School of Acupuncture/NFKA. These six gave real and false acupuncture, whereas the others, who had been trained in acupuncture by the six, were allowed only to give false acupuncture. The rationale for choice of control or comparator should be presented and justifi ed in relation to the research question and the methodology. In studies in which a group receiving acupuncture is compared with another group, the control or comparator can be sham acupuncture, usual care, an active treatment, a waiting list or no treatment. Whereas 'control' is sometimes used for a group that receives no intervention, the term 'comparator' may be more appropriate for an active intervention, such as physiotherapy, for which the intended action of the comparator is expected to be therapeutic. If using an acupuncturelike control in a participant-blinded trial then one of the following terms: active acupuncture control, penetrating needle control or non-penetrating sham needling control might be helpful descriptors. Control procedures involving invasive or non-invasive sham needling techniques may be therapeutically active, evoking neurophysiological and/or localised immune and circulatory responses. The extent to which sham acupuncture needling, whether penetrating or not, might elicit acupuncture-specifi c physiological mechanisms is not known, and is in part a consequence of our lack of knowledge of the mechanism(s) of true acupuncture.
There are also variations in assumptions about the precision required for point location, as for some clinicians and investigators acupuncture points are considered as areas of reactivity rather than points of action. Such assumptions have a bearing on the integrity of the sham as an appropriate control. Some non-needling control procedures can be assumed to be physiologically inert, such as an inactivated transcutaneous electrical nerve stimulation machine; however, these procedures may not have the same total psychophysiological credibility as acupuncture, thereby compromising the interpretation of the results. Sources that led to the choice of control, such as literature or expert opinion, should also be reported and referenced. The author should reference prior work that supports the use of the selected comparator, such as from the conclusion of a systematic review or from another randomised controlled trial.
Examples
(A) 'Sham' acupuncture points were chosen from three different areas on the body (the anterior thigh distally, the posterior thigh and the lateral aspect of the lower back), which do not correspond to recognised acupuncture points and are deemed to have no therapeutic value. to participants in another setting. Where usual care is also provided to those receiving acupuncture, these data will also allow readers to compare the intensity of usual care in the comparator arm with that of the experimental arm. If it is a waiting list arm, then the period of waiting needs to be specifi ed. While precise description of the control or comparator is fairly straightforward in principle, the more complex the components, the more care is required to specify them precisely.
(A) Acupuncturists inserted two needles into the sham points in the abdominal area, approximately 3 cm lateral to and slightly above the umbilicus bilaterally and then immediately applied two pieces of adhesive tape next to the needles. In addition, they tapped a mock plastic needle guiding tube on the surface of each of the nine true points in the leg to produce some discernible sensation and then immediately applied a needle with a piece of adhesive tape to the dermal surface, without needle insertion, of each point for a total of 20 min. The sham acupuncture procedure was given on the same schedule as the experimental group and used the same active needle placements, except actual insertion did not occur at these nine points. Although electrical stimulation did not occur, a mock transelectrical stimulation unit (which emitted a sound and possessed a blinking light) was attached to the sham needles at the knee. To facilitate blinding, we used screens in both treatment and sham groups which were placed below the abdomen to prevent participants from actually observing the true or sham procedures at the knee area but to allow them to observe the procedure being performed in the abdomen area.
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(B) In each session, at least fi ve out of 10 predefi ned distant non-acupuncture points (ref) were needled bilaterally (at least 10 needles) and superfi cially using fi ne needles (ie, minimal acupuncture). 'De qi' and manual stimulation of the needles were avoided. All acupuncturists received oral instructions, a videotape and a brochure with detailed information on sham acupuncture. Training of more superfi cial muscles in dynamic exercises to improve mobility, strength and endurance capacity was gradually included. Patients received treatments individually for a total of 6 h during 6 weeks. They were told to integrate the exercises in daily activities and to exercise in short sessions on several occasions during the day.
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DISCUSSION
This revised STRICTA statement has been designed to help improve the reporting of interventions in clinical trials of acupuncture, with the intention that it will help authors of acupuncture trials provide readers with a clear, accurate and transparent account of their acupuncture protocols as well as their control and/or comparator procedures. In addition to revising the STRICTA checklist, we have improved the explanations of each item and provided examples of good reporting. To enhance awareness, endorsement and adherence, the revised STRICTA statement has been developed as an extension to CONSORT. Authors of clinical trials of acupuncture should use the STRICTA recommendations for the acupuncture intervention (item 5 in the CONSORT 2010 statement) in conjunction with the other 25 items of the checklist in the main CONSORT guidelines. 10 11 The extension to CONSORT for non-pharmacological interventions is also highly relevant to acupuncture trials. 14 15 There are other extensions to CONSORT that may be relevant, depending on the type of trial design, including extensions for cluster trials, equivalence and noninferiority trials and pragmatic trials, and the reporting of abstracts and of harms (eg, adverse events) associated with the intervention. The most recent versions of all CONSORT guidance documents can be found on the CONSORT website (http:// www.consort-statement.org, accessed 16 April 2010).
A complete, accurate and transparent trial report facilitates dissemination, interpretation, translation and replicability. There continues to be a need for better reporting generally, as has been highlighted in a recent study of what is missing from descriptions of treatments in trials and reviews. 55 The authors found that elements of the intervention were missing in half of the published articles that they reviewed, giving insuffi cient detail-for example, with practitioners unable to use the treatments as described and researchers unable to replicate studies. This fi nding is similar to that from a review of authors of acupuncture trials. 12 Improved reporting reduces reader ambiguity in interpretation, is likely to increase credibility and application of the results by providing better evidence on which to base decisions on patient care. Reporting guidelines do help to improve the quality of reporting randomised trials, 56 although it is diffi cult to observe their maximal benefi t because too few journals endorse reporting guidelines 57 and fewer adhere to them. 57 To maximise this potential, we encourage journals to unambiguously endorse the revised STRICTA reporting guidelines. This can be most readily achieved by updating journal Instructions to Authors, thereby alerting prospective authors. In addition, we encourage journals to implement strategies to improve author adherence to reporting guidelines. These efforts might also help peer reviewers and journal editors in deliberating the merits of such trials.
Members of the STRICTA Revision and Steering Groups
The Steering Group comprised DA and DM (CONSORT), HM and RH (STRICTA) and YL and TW (Chinese Cochrane Centre). The STRICTA Revision Group, who participated in the consensus-building workshop in Freiburg, comprised the six members of the Steering Group and Stephen
